BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 29875409)

  • 21. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
    Patel KM; Strong A; Tohyama J; Jin X; Morales CR; Billheimer J; Millar J; Kruth H; Rader DJ
    Circ Res; 2015 Feb; 116(5):789-96. PubMed ID: 25593281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cholesterol loading capacity of macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Marchi C; Zimetti F; Budoff MJ; Ronda N
    Rheumatology (Oxford); 2023 Mar; 62(3):1254-1263. PubMed ID: 35809057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
    Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
    Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO
    Circulation; 2009 Aug; 120(5):417-26. PubMed ID: 19620499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
    Dou H; Kotini A; Liu W; Fidler T; Endo-Umeda K; Sun X; Olszewska M; Xiao T; Abramowicz S; Yalcinkaya M; Hardaway B; Tsimikas S; Que X; Bick A; Emdin C; Natarajan P; Papapetrou EP; Witztum JL; Wang N; Tall AR
    Circulation; 2021 Dec; 144(24):1940-1954. PubMed ID: 34846914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory profile of oxidized phospholipids.
    Bochkov VN
    Thromb Haemost; 2007 Mar; 97(3):348-54. PubMed ID: 17334500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) accelerates atherosclerosis in uremic mice.
    Pedersen TX; McCormick SP; Tsimikas S; Bro S; Nielsen LB
    J Lipid Res; 2010 Oct; 51(10):2967-75. PubMed ID: 20584868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
    Leibundgut G; Arai K; Orsoni A; Yin H; Scipione C; Miller ER; Koschinsky ML; Chapman MJ; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2012 Apr; 59(16):1426-37. PubMed ID: 22497821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).
    Handa JT; Tagami M; Ebrahimi K; Leibundgut G; Janiak A; Witztum JL; Tsimikas S
    Trans Am Ophthalmol Soc; 2015; 113():T5. PubMed ID: 26538774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
    Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
    J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice.
    Palmieri M; Almeida M; Nookaew I; Gomez-Acevedo H; Joseph TE; Que X; Tsimikas S; Sun X; Manolagas SC; Witztum JL; Ambrogini E
    Aging Cell; 2021 Aug; 20(8):e13442. PubMed ID: 34278710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fortilin reduces apoptosis in macrophages and promotes atherosclerosis.
    Pinkaew D; Le RJ; Chen Y; Eltorky M; Teng BB; Fujise K
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1519-29. PubMed ID: 24043250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.